BioSpace News Archive

Business

Mammoth Biosciences Comes out of Stealth Mode to Use CRISPR Tech to Diagnose Diseases

Mammoth Biosciences, based in San Francisco, has officially launched to develop CRISPR technology for clinical diagnostics.

April 26, 2018

·

3 min read

·

Mark Terry

Business

Report Reveals Biotech CEO Salaries Compared to Median Employee Pay in the Bay State

The difference between the salaries paid to top executives and the median income earned by rank and file employees has been a sore subject for many years and has served as a wedge political issue in recent elections.

April 26, 2018

·

2 min read

·

Alex Keown

Policy

Are Pharma Companies Ready for GDRP to Go into Effect in Europe?

Data protection has been on the minds of people in and out of the biotech sector for months. Next month the rules on holding private data for companies in Europe will change and that is forcing U.S.-based pharma companies to plan.

April 26, 2018

·

2 min read

·

Alex Keown

Are Pharma Investments in R&D Redundant?

Is it possible for the pharma industry to invest too much money into research and development projects for one disease area? In an online essay Jay Bradner, president of Novartis’ Institutes for BioMedical Research, expressed some concern, particularly in areas like cancer research.

April 26, 2018

·

2 min read

·

Alex Keown

Policy

Acadia Pharma Stock Plummets After FDA Head Tells Congress Parkinson’s Drug Under Investigation

Acadia Pharmaceuticals shares dropped 22 percent yesterday after U.S. Food and Drug Administration (FDA) commissioner Scott Gottlieb told Congress the agency would investigate the company’s Nuplazid.

April 26, 2018

·

2 min read

·

Mark Terry

Some useful tips to face and conquer the first day

How to Find Your Next Mentor

Having a mentor can help you effectively navigate your career. Since most life science professionals understand the value of having a mentor, why don’t they have one?

April 26, 2018

·

4 min read

·

Porschia Parker

Business

Strong Sales of Humira, Imbruvica and HCV Drug Mavyret Drive AbbVie’s Strong First Quarter

Humira, the world’s best-selling drug, keeps on churning out positive sales results for AbbVie, despite looming challenges.

April 26, 2018

·

3 min read

·

Alex Keown

Policy

Is the Push for Lower Drug Prices Surging Again?

During the 2016 U.S. presidential election, the push for lower drug prices became one of the hot-button topics. Now there appears to be some efforts by advocacy groups and government entities to tackle the subject in several different ways.

April 26, 2018

·

4 min read

·

Mark Terry

Drug Development

Saniona Cleared to Continue Phase II Prader-Willi Syndrome Treatment Program

Shares of Denmark-based Saniona are up more than 14 percent on the Stockholm Exchange after the company announced it has been cleared to initiate the second part of a mid-stage trial to develop a treatment for adolescents with Prader-Willi Syndrome.

April 26, 2018

·

3 min read

·

Alex Keown

Business

French Insulin Maker Spurned by Eli Lilly Forges Deal with China’s Tonghua Dongbao

Shares of Adocia are up nearly 30 percent this morning after the company announced it granted exclusive development and commercialization rights of its insulin products to Tonghua Dongbao Pharmaceuticals.

April 26, 2018

·

3 min read

·

Mark Terry